Four writers. One standard.
Aminoscope is published by MEAS Partners, LLC. Our writers publish under consistent pen names — a common practice in health and science journalism — so the work is judged on its sourcing rather than on personality.
Bylines are stable: the same name always means the same writer, and every claim is anchored to a citation you can verify yourself. Each writer holds an ORCID iD registered to Aminoscope, Newark, Delaware, US, providing a persistent, machine-readable link between the byline and the work.
Julian Roth
Research & dataTrials, effect sizes, and the primary literature.
ORCID: 0009-0002-5598-5313
View profile →Nadia Feldman
Access & costCost, coverage, access pathways, and side-effect timelines.
ORCID: 0009-0006-9524-0390
View profile →Priya Anand
Pharmacology & mechanismsReceptors, half-lives, drug interactions, and where mechanism outruns evidence.
ORCID: 0009-0009-6670-0855
View profile →Theo Lindqvist
Peptides & longevityPeptides, NAD+, senolytics, and healthspan — graded by human evidence.
ORCID: 0009-0009-2553-5574
View profile →Read more about our editorial standard in our methodology and disclosures.